Updated Pediatric and Adult Obesity Algorithm

Slideshow

How will the updated pediatric and adult obesity algorithm impact both your patients and practice? Scroll through this slideshow to find out. 

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
nt Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists / image credit ©syahrir/stock.adobe.com

Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists

Grace Halsey
August 19th 2025
Article
The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

Sydney Jennings
August 19th 2025
Podcast
Viking's Oral Dual Incretin Agonist VK2735 Produces Up to 12% Weight Loss at 13 Weeks in Phase 2 Trial

Viking's Oral Dual Incretin Agonist VK2735 Produces Up to 12% Weight Loss at 13 Weeks in Midstage Trial

Grace Halsey
August 19th 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 19th 2025
Podcast
Preparing for the 2025-26 Respiratory Virus Season: A Q&A With Sarah Sams, MD

Preparing for the 2025-26 Respiratory Virus Season: A Q&A With Sarah Sams, MD

Sarah Sams, MD;Sydney Jennings
August 19th 2025
Article
Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update / image credit UVA Health Anita Clayton, MD

Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update

Grace Halsey
August 19th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.